Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination

p53 gene mutation is the most common genetic alteration in neoplastic diseases, including breast cancer, for which p53 alteration may indicate poor prognosis. Recent clinical evidence suggests that prostate-specific antigen (PSA) expression may identify breast cancer patients with favourable outcome...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, H, Levesque, M A, Clark, G M, Diamandis, E P
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362935/
https://www.ncbi.nlm.nih.gov/pubmed/10507775
http://dx.doi.org/10.1038/sj.bjc.6690720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362935/
https://www.ncbi.nlm.nih.gov/pubmed/10507775
http://dx.doi.org/10.1038/sj.bjc.6690720

Ejemplares similares